S&P 500 contracts jumped after the company said its vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial.
S&P 500 contracts jumped after the company said its vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial.